SD Biosensor (137310) stock
KOSPI · Health Care Equipment & Supplies
As of Nov 16, 12:55 PM KST
- Market cap
- KRW 881.5 billion
- As of Nov 16, 2026
- P/E
- -1.06x
- Trailing twelve months
- P/B
- 0.37x
- Latest reported equity
- P/S
- 1.15x
- Trailing twelve months
- ROE
- -34.5%
- Trailing twelve months
- Dividend yield
- 2.74%
- Dividends observed in the last year
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
- Market cap
- KRW 881.5 billion
- As of Nov 16, 2026
- P/E
- -1.06x
- Trailing twelve months
- P/B
- 0.37x
- Latest reported equity
- P/S
- 1.15x
- Trailing twelve months
- ROE
- -34.5%
- Trailing twelve months
- Dividend yield
- 2.74%
- Dividends observed in the last year
Multiples use the price as of Nov 16, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
-1.06x
Net loss — not comparable
P/B
0.37x
P/S
1.15x
Earnings and dividend metrics▾
Earnings
EPS
-KRW 6,882
Earnings per share
BPS
KRW 19,924
Book value per share
ROE
-34.5%
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at KRW 6,882 per share.
- BPS — net assets divided by the number of shares. Each share is backed by KRW 19,924 of net assets.
- ROE — shareholder equity shrank by 34.5% over a year.
Dividends
1 observed in the last year · Record dates: Mar
Yield
2.74%
Dividend per share
KRW 200
Consecutive years
2+ yrs
Yield uses dividends observed over the last year (by record date) · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about KRW 20,000 before tax.
- Consecutive years — dividends were paid every year for more than 2 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from DART financial filings: net income attributable to owners of the parent and revenue are summed over the latest four quarters, equity is the latest reported equity, and prices are KRX closing prices.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Earnings
Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| Q2 2026Consolidated · Filed Aug 14, 2026 | KRW 186.5 billion | -KRW 7.3 billion | KRW 16.3 billion | +12.0% |
| Q1 2026Consolidated · Filed May 14, 2026 | KRW 193.5 billion | -KRW 11.6 billion | KRW 22.3 billion | +4.4% |
| Q4 2025Consolidated · Filed Mar 18, 2026 | KRW 194.6 billion | -KRW 31.8 billion | -KRW 759.8 billion | — |
| Q3 2025Consolidated · Filed Nov 13, 2025 | KRW 164.2 billion | -KRW 14 billion | -KRW 9.9 billion | -3.8% |
| Q2 2025Consolidated · Filed Aug 13, 2025 | KRW 166.5 billion | -KRW 20.6 billion | KRW 275.1 billion | -0.6% |
| Q1 2025Consolidated · Filed May 14, 2025 | KRW 185.3 billion | -KRW 14.6 billion | -KRW 18.8 billion | +5.1% |
| Period | Revenue | Operating profit | Net income | Revenue YoY |
|---|---|---|---|---|
| FY2025Consolidated · Filed Mar 18, 2026 | KRW 710.6 billion | -KRW 80.9 billion | -KRW 513.4 billion | — |
| FY2024Consolidated · Filed Aug 22, 2025 | KRW 694.6 billion | -KRW 54.1 billion | -KRW 98.1 billion | — |
- Q2 2026 is computed as H1 2026 minus Q1 2026.
- Q4 2025 is computed as FY2025 minus 9M 2025.
- Q3 2025 is computed as 9M 2025 minus H1 2025.
- Q2 2025 is computed as H1 2025 minus Q1 2025.
Short selling and securities lending
Short sales as a share of trading value, the reported short position and the securities lending balance.
- Short-sale share
- 13.02%
- Of trading value on Nov 13, 2026
- Short-sale value
- KRW 140 million
- Previous 20-day average 9.48%
- Net short position
- 236,107 shares
- As of Nov 11, 2026 · reported with a two-trading-day lag
- Lending balance
- 2,954,751 shares
- As of Nov 13, 2026 · 2.45% of listed shares
| Date | Share | Value |
|---|---|---|
| Nov 13, 2026 | 13.02% | KRW 140 million |
| Nov 12, 2026 | 8.00% | KRW 100 million |
| Nov 11, 2026 | 8.00% | KRW 120 million |
| Nov 10, 2026 | 4.82% | KRW 230 million |
| Nov 9, 2026 | 8.87% | KRW 100 million |
| Nov 6, 2026 | 14.91% | KRW 170 million |
| Nov 5, 2026 | 14.04% | KRW 140 million |
| Nov 4, 2026 | 10.79% | KRW 60 million |
| Nov 3, 2026 | 14.20% | KRW 60 million |
| Nov 2, 2026 | 8.89% | KRW 50 million |
The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.
Filings
Major filings received by DART, Korea’s regulatory filing system.
- [Amended] Decision on Share BuybackNov 10, 2026 · Share BuybackEnglish
- Decision on Share Buyback(Korean)Nov 10, 2026 · Share Buyback
- Corporate Value-up Plan (Voluntary)(Korean)Oct 28, 2026 · Corporate Value-up Plan
- Corporate Value-up Plan(Korean)Oct 22, 2026
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Sep 22, 2026 · Insider Ownership Report
- Report on Major Holdings of Shares (General Form)(Korean)Aug 20, 2026 · Major Holding Report
- Report on Specified Securities Held by Executives and Major Shareholders(Korean)Aug 12, 2026 · Insider Ownership Report
- Decision on Lending of Funds(Korean)Jul 10, 2026 · Debt Guarantee or Loan
Filings with a published English version open in English; the rest link to the Korean original.
SD Biosensor (137310) stock information
KOSPI
SD Biosensor (137310) is listed on KOSPI. Its market capitalization is about KRW 881.5 billion. On trailing-twelve-month earnings the P/E ratio is -1.06, and the P/B ratio is 0.37. Return on equity is -34.5%. These figures are computed in-house from official filings and are reference information only.
SD Biosensor — frequently asked questions
- What is the P/E ratio of SD Biosensor (137310)?
- On a trailing-twelve-month basis, 137310 trades at a P/E ratio of -1.06. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of SD Biosensor?
- 137310 has a market capitalization of about KRW 881.5 billion. The figure moves with the share price and is refreshed each trading day.
- Does SD Biosensor pay a dividend?
- 137310 has a dividend yield of about 2.74%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.